
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
In October of this year,
Currently PRA has a Bioanalytical Laboratory facility located in Assen, The Netherlands. This is a GLP-compliant laboratory began operating in the mid 1980's. The facility's analytical capabilities include:






